Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Surprises Stock Declines PFLT Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short DKS Q1 2026 Earnings EPS Surge Powers Strong Beat Despite Revenue Gap Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones Skillz Q1 2026 Earnings EPS Misses Estimates as Revenue Data Remains Withheld XPON Q2 2025 Earnings EPS Beats Estimates by 307 Despite Absent Revenue Data